Hematopoietic growth factors and transfusion medicine.
Transfus Med Rev
; 12(3): 195-205, 1998 Jul.
Article
en En
| MEDLINE
| ID: mdl-9673004
ABSTRACT
At least 20 different hematopoietic drugs (see Table 1) are currently under investigation. These most likely will impact on all aspects of transfusion therapy. Which agents to use and in what combinations will be the subject of scrutiny for many years to come as scientists try to recreate and enhance the process of hematopoiesis. Perhaps someday blood cells and hematopoietic progenitor cells can be manufactured for therapy with genetically selected phenotypes to avoid immune destruction and rejection. If this comes to pass, blood donations as we know them today, as a valuable adjunct to medical care, will fade into history, supplanted by the use of hematopoietic growth factors.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Factores de Crecimiento de Célula Hematopoyética
/
Transfusión de Componentes Sanguíneos
Límite:
Humans
Idioma:
En
Revista:
Transfus Med Rev
Asunto de la revista:
HEMATOLOGIA
Año:
1998
Tipo del documento:
Article
País de afiliación:
Estados Unidos